SUBSCRIBE
SUBSCRIBE
News   FDA

New Warnings for Genentech, OSI Pharmaceuticals, Inc. Tarceva Cancer Drug

May 11, 2009 | 
1 min read
Reuters -- New warnings have been added to Genentech Inc and OSI Pharmaceutical Inc's cancer drug Tarceva about reports of skin reactions, eye problems and holes in the digestive tract, U.S. health regulators said on Friday.
FDA Approvals
Genentech, Inc.
MORE ON THIS TOPIC
Illustration showing a downward graph trend
Regulatory
Future of Aardvark’s Prader-Willi drug in doubt as FDA slaps full hold on program
May 15, 2026
 · 
2 min read
 · 
Tristan Manalac
Lightbulb with tangled lines. Problem solving and brainstorming Idea concept. Vector illustration
Gene therapy
REGENXBIO slumps after serious side effects mar Duchenne gene therapy results
May 14, 2026
 · 
3 min read
 · 
Annalee Armstrong
Businessperson group is walking towards career success or a vacant promotion competition. isometric vector illustration.
FDA
Biotech leaders pitch Pazdur as next FDA chief
May 14, 2026
 · 
2 min read
 · 
Annalee Armstrong
Editable vector illustration of a man winning a race. Hi-res jpeg file included.
Approvals
BeOne wins mantle cell lymphoma approval, opening new therapy class
May 14, 2026
 · 
2 min read
 · 
Tristan Manalac